Phase I study on safety and pharmacokinetics of a novel influenza endonuclease inhibitor, AL-794 (JNJ-64155806), following single- and multiple-ascending doses in healthy adults
Kakuda, Thomas N, Yogaratnam, Jeysen, Rito, Jennifer, Boyce, Malcolm, Mitchell, Toni, Gupta, Kusum, Symons, Julian A, Chanda, Sushmita, Van Remoortere, Pieter, Fry, JohnYear:
2018
Language:
english
Journal:
Antiviral Therapy
DOI:
10.3851/IMP3244
File:
PDF, 7.94 MB
english, 2018